Cengild Medical Berhad (KLSE: CENGILD)
Malaysia
· Delayed Price · Currency is MYR 0.275
+0.005 (1.85%)
At close: Dec 20, 2024
Cengild Medical Berhad Income Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2018 |
| Revenue | 71.54 | 66.85 | 70.28 | 64.44 | 63.47 | 39.18 | Upgrade
|
| Revenue Growth (YoY) | 1.81% | -4.88% | 9.06% | 1.53% | 62.00% | 39.02% | Upgrade
|
| Cost of Revenue | 38.23 | 35.76 | 39.55 | 38.39 | 36.79 | 21.67 | Upgrade
|
| Gross Profit | 33.31 | 31.09 | 30.73 | 26.05 | 26.68 | 17.51 | Upgrade
|
| Selling, General & Admin | 20.15 | 18.76 | 16.24 | 14.48 | 12.21 | 10.48 | Upgrade
|
| Other Operating Expenses | 0.02 | - | - | - | - | 0.01 | Upgrade
|
| Operating Expenses | 20.17 | 18.76 | 16.26 | 14.48 | 12.21 | 10.49 | Upgrade
|
| Operating Income | 13.14 | 12.33 | 14.46 | 11.57 | 14.47 | 7.02 | Upgrade
|
| Interest Expense | -0.54 | -0.63 | -0.73 | -0.85 | -1.22 | -1.58 | Upgrade
|
| Earnings From Equity Investments | -0.33 | -0.35 | - | - | -0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 4.49 | 4.49 | 3.65 | 1.39 | 0.22 | - | Upgrade
|
| EBT Excluding Unusual Items | 16.76 | 15.84 | 17.37 | 12.11 | 13.47 | 5.44 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0.1 | Upgrade
|
| Pretax Income | 16.76 | 15.84 | 17.37 | 12.11 | 13.47 | 5.53 | Upgrade
|
| Income Tax Expense | 5.28 | 4.77 | 4.09 | 2.72 | 3.46 | 1.58 | Upgrade
|
| Net Income | 11.48 | 11.08 | 13.29 | 9.39 | 10 | 3.95 | Upgrade
|
| Net Income to Common | 11.48 | 11.08 | 13.29 | 9.39 | 10 | 3.95 | Upgrade
|
| Net Income Growth | -13.49% | -16.64% | 41.50% | -6.13% | 153.15% | 167.66% | Upgrade
|
| Shares Outstanding (Basic) | 833 | 833 | 819 | 644 | 600 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | 833 | 834 | 826 | 645 | 600 | 13 | Upgrade
|
| Shares Change (YoY) | 0.58% | 1.00% | 27.94% | 7.56% | 4700.00% | - | Upgrade
|
| EPS (Basic) | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | 0.32 | Upgrade
|
| EPS (Diluted) | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | 0.32 | Upgrade
|
| EPS Growth | -13.88% | -17.39% | 10.46% | -12.59% | -94.73% | 167.66% | Upgrade
|
| Free Cash Flow | -3.62 | -2.8 | 11.78 | 14.9 | 12.6 | 10.63 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | 0.01 | 0.02 | 0.02 | 0.85 | Upgrade
|
| Dividend Per Share | 0.007 | 0.007 | 0.007 | 0.004 | - | - | Upgrade
|
| Dividend Growth | 0% | 0% | 100.00% | - | - | - | Upgrade
|
| Gross Margin | 46.56% | 46.51% | 43.72% | 40.43% | 42.03% | 44.70% | Upgrade
|
| Operating Margin | 18.37% | 18.45% | 20.58% | 17.95% | 22.79% | 17.92% | Upgrade
|
| Profit Margin | 16.05% | 16.57% | 18.91% | 14.57% | 15.76% | 10.09% | Upgrade
|
| Free Cash Flow Margin | -5.05% | -4.19% | 16.77% | 23.12% | 19.85% | 27.13% | Upgrade
|
| EBITDA | 16.46 | 14.88 | 16.33 | 14.56 | 17.56 | 9.92 | Upgrade
|
| EBITDA Margin | 23.01% | 22.26% | 23.23% | 22.60% | 27.67% | 25.33% | Upgrade
|
| D&A For EBITDA | 3.33 | 2.55 | 1.87 | 2.99 | 3.1 | 2.9 | Upgrade
|
| EBIT | 13.14 | 12.33 | 14.46 | 11.57 | 14.47 | 7.02 | Upgrade
|
| EBIT Margin | 18.37% | 18.45% | 20.58% | 17.95% | 22.79% | 17.92% | Upgrade
|
| Effective Tax Rate | 31.50% | 30.08% | 23.52% | 22.48% | 25.72% | 28.59% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.